ArticleInternal medicine (Tokyo, Japan)2025
First Reported Case of Pure Red Cell Aplasia Related to Sotorasib.
Katsuhiro Itogawa, Tatsuya Saito, Yuya Nakata, Hikari Amari, Hiroki Tahara, Nozomu Yoshino, Yuki Maeda, Motoko Nomura, Jun Shiihara, Yoshiaki Nagai and 2 more
Abstract readCase Reports
In one paragraphArticle in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Katsuhiro ItogawaDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Tatsuya SaitoDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Yuya NakataDivision of Hematology, Jichi Medical University Saitama Medical Center, Japan.
Hikari AmariDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Hiroki TaharaDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Nozomu YoshinoDivision of Hematology, Jichi Medical University Saitama Medical Center, Japan.
Yuki MaedaDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Motoko NomuraDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Jun ShiiharaDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Yoshiaki NagaiDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Hiromitsu OhtaDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Yasuhiro YamaguchiDivision of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Japan.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
We herein report a 64-year-old man with KRAS
Indexed as
Immune Checkpoint InhibitorsLung NeoplasmsPiperazinesPyridinesRed-Cell Aplasia, PureAdenocarcinoma of LungHumansMaleMiddle AgedProto-Oncogene Proteins p21(ras)Immune Checkpoint InhibitorsKRAS protein, humanPiperazinesProto-Oncogene Proteins p21(ras)Pyridinesimmune checkpoint inhibitorimmune related adverse eventslung cancerpure red call aplasiasotorasib
Identifiers
PMID39231674
PMCPMC12021511
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390